CFM
CLB icon

Catalyst Funds Management’s Core Laboratories CLB Stock Holding History

Catalyst Funds Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600
Closed -$12.2K – 1343
2024
Q2 		$12.2K Buy
+600
New +$10.6K ﹤0.01% 856

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Catalyst Funds Management's CLB Position: Q3 2024 in Review

Catalyst Funds Management sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 600 shares — an estimated $12.2K sold.

Catalyst Funds Management first reported a position in CLB in Q2 2024 and held it in 1 quarter. The position peaked at $12.2K in Q2 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • Catalyst Funds Management reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 600 Core Laboratories shares in Q3 2024, an estimated $12.2K.
  • Catalyst Funds Management first reported a position in Core Laboratories in Q2 2024 and held it in 1 quarter.
  • Catalyst Funds Management's Core Laboratories position peaked at $12.2K in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on Catalyst Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.